Clark Capital Management Group »

SPDR S&P Pharmaceuticals shares owned by Clark Capital Management Group

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Clark Capital Management Group from 13F filings

Historical chart of Clark Capital Management Group investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Clark Capital Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Clark Capital Management Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.2M 47k 47.94
2022-06-30 $4.7M 112k 42.00
2019-12-31 $1.9M 41k 45.67

More positions owned by Clark Capital Management Group

Ishares Tr Iboxx Hi Yd Etf (HYG)
Spdr Series Trust Portfolio S&p500 (SPLG)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Series Trust Bloomberg High Y (JNK)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Total (IXUS)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Nvent Electric SHS (NVT)
Johnson & Johnson (JNJ)
Abbvie (ABBV)

View all positions for Clark Capital Management Group

Top funds holding SPDR S&P Pharmaceuticals

Morgan Stanley
Envestnet Asset Management
LPL Financial
First Citizens Bank & Trust
Envestnet Portfolio Solutions
Goldman Sachs Group
Susquehanna International
Wells Fargo & Company
Cetera Investment Advisers
Jpmorgan Chase & Co
CX Institutional
Wharton Business Group
Clark Capital Management Group
Bp Wealth Management
Bnp Paribas Arbitrage, Snc

View all funds holding SPDR S&P Pharmaceuticals